JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB318008

Alexa Fluor® 594 Anti-beta Catenin non-phospho S37/T41 antibody [EPR23969-131]

Be the first to review this product! Submit a review

|

(0 Publication)

Rabbit Recombinant Monoclonal beta Catenin antibody - conjugated to Alexa Fluor® 594.

View Alternative Names

CTNNB, OK/SW-cl.35, PRO2286, CTNNB1, Catenin beta-1, Beta-catenin

  • 578 PE

    PE Anti-beta Catenin non-phospho S37/T41 antibody [EPR23969-131]

  • 660 APC

    APC Anti-beta Catenin non-phospho S37/T41 antibody [EPR23969-131]

  • 519 Alexa Fluor® 488

    Alexa Fluor® 488 Anti-beta Catenin non-phospho S37/T41 antibody [EPR23969-131]

  • 565 Alexa Fluor® 555

    Alexa Fluor® 555 Anti-beta Catenin non-phospho S37/T41 antibody [EPR23969-131]

  • 665 Alexa Fluor® 647

    Alexa Fluor® 647 Anti-beta Catenin non-phospho S37/T41 antibody [EPR23969-131]

  • 775 Alexa Fluor® 750

    Alexa Fluor® 750 Anti-beta Catenin non-phospho(active) S37/T41 antibody [EPR23969-131]

  • Unconjugated

    Anti-beta Catenin non-phospho S37/T41 antibody [EPR23969-131]

  • Carrier free

    Anti-beta Catenin non-phospho S37/T41 antibody [EPR23969-131] - BSA and Azide free

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EPR23969-131

Isotype

IgG

Conjugation

Alexa Fluor® 594

Excitation/Emission

Ex: 590nm, Em: 617nm

Carrier free

No

Applications

Antibody Labelling, Target Binding Affinity

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Product details

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

How are conjugated primary antibodies validated?
This conjugated primary antibody is released using a quantitative quality control method that evaluates binding affinity post-conjugation and efficiency of antibody labeling.
For suitable applications and species reactivity, please refer to the unconjugated version of this clone.

Alexa Fluor® is a registered trademark of Molecular Probes, Inc, a Thermo Fisher Scientific Company. The Alexa Fluor® dye included in this product is provided under an intellectual property license from Life Technologies Corporation. As this product contains the Alexa Fluor® dye, the purchase of this product conveys to the buyer the non-transferable right to use the purchased product and components of the product only in research conducted by the buyer (whether the buyer is an academic or for-profit entity). As this product contains the Alexa Fluor® dye the sale of this product is expressly conditioned on the buyer not using the product or its components, or any materials made using the product or its components, in any activity to generate revenue, which may include, but is not limited to use of the product or its components: in manufacturing; (ii) to provide a service, information, or data in return for payment (iii) for therapeutic, diagnostic or prophylactic purposes; or (iv) for resale, regardless of whether they are sold for use in research. For information on purchasing a license to this product for purposes other than research, contact Life Technologies Corporation, 5781 Van Allen Way, Carlsbad, CA 92008 USA or outlicensing@thermofisher.com.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.4 Preservative: 0.02% Sodium azide Constituents: PBS, 30% Glycerol (glycerin, glycerine), 1% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle|Store in the dark

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Beta-catenin non-phospho S37/T41 also known as unphosphorylated beta-catenin is an important form of the beta-catenin protein. The mass of beta-catenin is approximately 88 kDa. This protein plays an active role in cell signaling and adhesion mechanics. It is expressed throughout various tissues particularly abundant in epithelial cells. The non-phospho form of beta-catenin in particular escapes degradation allowing it to accumulate and translocate into the nucleus where it influences gene transcription.
Biological function summary

Beta-catenin non-phospho S37/T41 affects cellular behavior by modulating gene expression. It acts as a core component of the Wnt signaling pathway particularly in the regulation of gene transcription. In this pathway beta-catenin associates with transcription factors such as TCF/LEF to regulate target gene expression involved in processes like cell proliferation and differentiation. Unphosphorylated beta-catenin binds with protein complexes that regulate adhesion to ensure proper communication between cells.

Pathways

Beta-catenin non-phospho S37/T41 plays a pivotal role in the Wnt pathway a critical regulator of cell fate decisions. Within this context beta-catenin's stabilization and nuclear activity are vital for the pathway's transcriptional output. It works closely with proteins like APC (adenomatous polyposis coli) and Axin which act as regulators of its phosphorylation. Additionally beta-catenin interacts with E-cadherin at the cell membrane within the adherens junctions contributing to cell-cell adhesion processes.

Beta-catenin non-phospho S37/T41 has significant implications in oncology and degenerative diseases. Its dysregulation is often observed in cancers where the aberrant accumulation leads to unchecked cell proliferation. Mutations or alterations in the related protein APC can lead to colorectal cancer as it fails to regulate beta-catenin effectively. Further alterations in the Wnt/beta-catenin pathway have also been linked to degenerative conditions indicating the broad impact of this target in pathological states.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Key downstream component of the canonical Wnt signaling pathway (PubMed : 17524503, PubMed : 18077326, PubMed : 18086858, PubMed : 18957423, PubMed : 21262353, PubMed : 22155184, PubMed : 22647378, PubMed : 22699938). In the absence of Wnt, forms a complex with AXIN1, AXIN2, APC, CSNK1A1 and GSK3B that promotes phosphorylation on N-terminal Ser and Thr residues and ubiquitination of CTNNB1 via BTRC and its subsequent degradation by the proteasome (PubMed : 17524503, PubMed : 18077326, PubMed : 18086858, PubMed : 18957423, PubMed : 21262353, PubMed : 22155184, PubMed : 22647378, PubMed : 22699938). In the presence of Wnt ligand, CTNNB1 is not ubiquitinated and accumulates in the nucleus, where it acts as a coactivator for transcription factors of the TCF/LEF family, leading to activate Wnt responsive genes (PubMed : 17524503, PubMed : 18077326, PubMed : 18086858, PubMed : 18957423, PubMed : 21262353, PubMed : 22155184, PubMed : 22647378, PubMed : 22699938). Involved in the regulation of cell adhesion, as component of an E-cadherin : catenin adhesion complex (By similarity). Acts as a negative regulator of centrosome cohesion (PubMed : 18086858). Involved in the CDK2/PTPN6/CTNNB1/CEACAM1 pathway of insulin internalization (PubMed : 21262353). Blocks anoikis of malignant kidney and intestinal epithelial cells and promotes their anchorage-independent growth by down-regulating DAPK2 (PubMed : 18957423). Disrupts PML function and PML-NB formation by inhibiting RANBP2-mediated sumoylation of PML (PubMed : 22155184). Promotes neurogenesis by maintaining sympathetic neuroblasts within the cell cycle (By similarity). Involved in chondrocyte differentiation via interaction with SOX9 : SOX9-binding competes with the binding sites of TCF/LEF within CTNNB1, thereby inhibiting the Wnt signaling (By similarity). Acts as a positive regulator of odontoblast differentiation during mesenchymal tooth germ formation, via promoting the transcription of differentiation factors such as LEF1, BMP2 and BMP4 (By similarity). Activity is repressed in a MSX1-mediated manner at the bell stage of mesenchymal tooth germ formation which prevents premature differentiation of odontoblasts (By similarity).
See full target information CTNNB1

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com